Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

G

GRCE

Grace Therapeutics Inc

2.16

Aug 17 • 3:59 PM ET 0.00 (0.00%)

2.14

Aftermarket • 7:34 PM ET -0.02 (-0.93%)

Healthcare Biotechnology USA Nano NASD

Peers: ATOS INMB LTRN NTRB RNXT VERU XLO QNTM OTLK TLPH

| Held by: VTI IWC

Scroll to Statements

Index	-
Market Cap	45.44M
Enterprise Value	31.68M
Income	-20.22M
Sales	0.00M
Book/sh	2.96
Cash/sh	0.65
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	5
IPO	May 06, 2011

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	0.73
P/C	3.30
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	11.47
Current Ratio	11.47
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	-1.18
EPS next Y	-0.56
EPS next Q	-0.13
EPS this Y	-40.13%
EPS next Y	15.37%
EPS next 5Y	-
EPS past 3/5Y	56.43% 43.17%
Sales past 3/5Y	- -
EPS Y/Y TTM	-43.60%
Sales Y/Y TTM	-
EPS Q/Q	-333.11%
Sales Q/Q	-
Earnings	Aug 13 BMO
EPS/Sales Surpr.	-603.79% -

Insider Own	23.76%
Insider Trans	0.00%
Inst Own	40.71%
Inst Trans	-1.04%
ROA	-33.74%
ROE	-36.19%
ROIC	-41.94%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-0.99%
SMA50	-5.56%
SMA200	-31.20%
Trades

Shs Outstand	16.27M
Shs Float	12.41M
Short Float	12.81%
Short Ratio	5.99
Short Interest	1.59M
52W High	5.18 -58.30%
52W Low	1.79 20.67%
Volatility	4.47% 5.76%
ATR (14)	0.12
RSI (14)	44.68
Beta	0.44
Rel Volume	0.37
Avg Volume	265.42K
Volume	99,369

Perf Week	2.37%
Perf Month	-12.55%
Perf Quarter	0.00%
Perf Half Y	-40.17%
Perf YTD	-37.57%
Perf Year	-33.74%
Perf 3Y	0.47%
Perf 5Y	-89.05%
Perf 10Y	-96.67%
Recom	1.00
Target Price	6.00
Prev Close	2.16
Price	2.16
Change %	0.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)